 |
市場調査レポート
商品コード
1448253
マイクロアレイ解析の世界市場：市場規模、シェア、成長分析 - タイプ別、用途別、産業予測（2024～2031年）Global Microarray Analysis Market Size, Share, Growth Analysis, By Type(DNA, Protein and others), By Application(Research applications, drug discovery) - Industry Forecast 2024-2031 |
||||||
| マイクロアレイ解析の世界市場：市場規模、シェア、成長分析 - タイプ別、用途別、産業予測（2024～2031年） |
|
出版日: 2024年03月07日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界のマイクロアレイ解析の市場規模は、2022年に50億6,000万米ドル、2023年に55億1,000万米ドルに達し、2024～2031年の予測期間中にCAGR 8.8%で成長し、2031年には108億1,000万米ドルに達すると予測されています。
マイクロアレイ解析の世界市場は急速に拡大しており、バイオテクノロジー産業の中でも高度に先進的な分野です。マイクロアレイ解析は、多数の遺伝子または遺伝子変異の発現レベルを同時に調べるために使用されるハイスループット技術を含みます。この市場は主に、個別化医療に対する需要の高まり、ゲノム研究の継続的な進歩、慢性疾患の有病率の増加によって活性化されています。マイクロアレイは、遺伝子発現プロファイリング、ジェノタイピング、エピジェネティクス、バイオマーカー探索など、幅広い用途を包含しています。
マイクロアレイ技術の出現は、研究者に広範な遺伝子発現パターンの調査、疾患に関連する遺伝子の同定、創薬プロセスの促進を可能にし、ゲノミクスおよび分子生物学研究に革命をもたらしました。さらに、マイクロアレイ解析と次世代シーケンシングやバイオインフォマティクスのような他の最先端技術との統合が、その可能性をさらに増幅し、市場の成長に拍車をかけています。
従来、この市場では北米が圧倒的な強さを誇ってきたが、これは確立された研究インフラとゲノミクス研究への多額の投資によるものです。しかし、アジア太平洋地域では、精密医療への注目の高まりと新興国におけるマイクロアレイ技術の採用増加により、大幅な成長が見込まれています。
ゲノム科学が進化を続ける中、マイクロアレイ解析市場は大きな成長と革新を遂げようとしています。このような軌道は、個別化医療、診断、治療開発の進歩を促進し、ヘルスケアの将来の展望を形作るものと期待されます。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
調査手法
- 情報調達
- セカンダリ・プライマリデータソース
- 市場規模の推定
- 市場の前提条件・制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
世界のマイクロアレイ解析市場：タイプ別
- 市場概要
- DNA
- プロテイン
世界のマイクロアレイ解析市場：用途別
- 市場概要
- 研究用途
- 創薬
- 病気診断
世界のマイクロアレイ解析市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Bio-Rad Laboratories（US）
- Agilent Technologies, Inc.（US）
- Thermo Fisher Scientific Inc.（US）
- Illumina, Inc.（US）
- PerkinElmer Inc.（US）
- Merck KGaA（Germany）
- GE Healthcare（US）
- Molecular Devices, LLC（US）
- Arrayit Corporation（US）
- Microarrays, Inc.（US）
- BioGenex（US）
- Oxford Gene Technology（OGT）（UK）
- Qiagen N.V.（Netherlands）
- Roche Diagnostics（Switzerland）
- Fluidigm Corporation（US）
- Affymetrix（US）
- Agendia NV（Netherlands）
- Applied Microarrays（US）
- Biocompare（US）
- Eppendorf AG（Germany）
The Global Microarray Analysis Market size was valued at USD 5.06 billion in 2022 and is poised to grow from USD 5.51 billion in 2023 to USD 10.81 billion by 2031, growing at a CAGR of 8.8% in the forecast period (2024-2031).
The Global Microarray Analysis Market is rapidly expanding and represents a highly advanced sector within the biotechnology industry. Microarray analysis involves a high-throughput technique used to simultaneously examine the expression levels of numerous genes or genetic variations. This market is primarily fueled by escalating demands for personalized medicine, continual advancements in genomic research, and the increasing prevalence of chronic illnesses. It encompasses a broad spectrum of applications, including gene expression profiling, genotyping, epigenetics, and biomarker discovery.
The emergence of microarray technologies has revolutionized genomics and molecular biology research by empowering researchers to investigate extensive gene expression patterns, identify genes associated with diseases, and facilitate drug discovery processes. Moreover, the integration of microarray analysis with other cutting-edge technologies like next-generation sequencing and bioinformatics has further amplified its potential and spurred market growth.
Traditionally, North America has been the dominant force in this market, benefiting from its well-established research infrastructure and substantial investments in genomics research. However, substantial growth is anticipated in the Asia-Pacific region, fueled by a burgeoning focus on precision medicine and an increasing adoption of microarray technologies in emerging economies.
As genomic science continues to evolve, the microarray analysis market is poised for significant growth and innovation. This trajectory is expected to drive advancements in personalized medicine, diagnostics, and therapeutic development, shaping the future landscape of healthcare.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microarray Analysis Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Microarray Analysis Market Segmental Analysis
Worldwide Microarray Analysis Markets are divided based on geography, type, and application. The market can be divided into segments according on type, such as DNA, Protein, and others. The market is divided into segments according to application, including illness diagnostics, drug discovery, and research applications. The market is divided into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America based on geographic factors.
Drivers of the Global Microarray Analysis Market
The growing need for personalized medication is one of the major factors propelling the global microarray analysis market. By customizing medical care to each patient according to their genetic composition, personalized medicine seeks to provide more accurate and potent treatments. Microarray analysis is essential to personalized therapy since it helps identify genetic variants linked to disease and provides comprehensive genomic information. The demand for microarray analysis is being driven by the increasing global use of personalized medicine techniques, which is also bolstering market growth.
Restraints in the Global Microarray Analysis Market
The high cost of microarray technology and analysis is a major barrier to the growth of the global microarray analysis market. Because microarray platforms, reagents, and instruments can be costly, some medical facilities and research institutes with limited funding may find it difficult to use them. The intricacy of the data analysis process and the need for specific knowledge might further raise the final cost. The high expense of microarray analysis can be a barrier to its broad use and commercial expansion, particularly in environments with limited resources. To overcome this constraint, efforts to lower expenses and raise affordability-such as improved processes and technological advancements-are crucial.
Market Trends of the Global Microarray Analysis Market
The integration of microarray analysis with other omics technologies is a significant industry development in the global microarray analysis market. In order to improve data analysis and interpretation, this movement combines microarray analysis with other cutting-edge technologies including next-generation sequencing (NGS) and bioinformatics. Researchers can get a complete picture of the genome, transcriptome, and epigenome by combining NGS and microarray analysis. This allows for a more thorough and in-depth examination of genetic variants and gene expression. With the help of this trend, scientists can better understand disease mechanisms, intricate biological processes, and applications of personalized medicine by combining the strengths of many technologies. Microarray analysis in conjunction with other omics technologies fosters synergistic developments and opens the door to more thorough and multidimensional molecular profiling methods.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Microarray Analysis Market by Type
- Market Overview
- DNA
- Protein and others
Global Microarray Analysis Market by Application
- Market Overview
- Research applications
- drug discovery
- disease diagnostics and others
Global Microarray Analysis Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Bio-Rad Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Illumina, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PerkinElmer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GE Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Molecular Devices, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Arrayit Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Microarrays, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioGenex (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Oxford Gene Technology (OGT) (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Qiagen N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fluidigm Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Affymetrix (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agendia NV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Applied Microarrays (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biocompare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eppendorf AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
